LTIP460A - Ophtalmic combinations of carbonic anhydrase inhibitors and b-blockers - Google Patents

Ophtalmic combinations of carbonic anhydrase inhibitors and b-blockers

Info

Publication number
LTIP460A
LTIP460A LTIP460A LTIP460A LTIP460A LT IP460 A LTIP460 A LT IP460A LT IP460 A LTIP460 A LT IP460A LT IP460 A LTIP460 A LT IP460A LT IP460 A LTIP460 A LT IP460A
Authority
LT
Lithuania
Prior art keywords
ophtalmic
blockers
combinations
carbonic anhydrase
anhydrase inhibitors
Prior art date
Application number
LTIP460A
Inventor
John J Baldwin
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24757446&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LTIP460(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of LTIP460A publication Critical patent/LTIP460A/en
Publication of LT3368B publication Critical patent/LT3368B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
LTIP460A 1991-04-17 1993-03-30 Ophtalmic combinations of carbonic anhydrase inhibitors and b-blockers LT3368B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68671891A 1991-04-17 1991-04-17

Publications (2)

Publication Number Publication Date
LTIP460A true LTIP460A (en) 1994-10-25
LT3368B LT3368B (en) 1995-08-25

Family

ID=24757446

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP460A LT3368B (en) 1991-04-17 1993-03-30 Ophtalmic combinations of carbonic anhydrase inhibitors and b-blockers

Country Status (4)

Country Link
US (1) US6248735B1 (en)
LT (1) LT3368B (en)
SG (1) SG84487A1 (en)
ZA (1) ZA922809B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI298257B (en) 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
US20040067992A1 (en) * 2001-08-10 2004-04-08 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia
LT5504B (en) 2006-08-02 2008-06-25 Biotechnologijos Institutas Benzimidazo[1,2-c][1,2,3]thiadiazol-7-sulfonamides as inhibitors of carbonic anhydrase and the intermediates for production thereof
TNSN08110A1 (en) * 2008-03-11 2009-07-14 Rekik Raouf Dr Drug delivery to the anterior and posterior segment of the eye from drops
CA2807081C (en) 2010-07-29 2018-09-18 Allergan, Inc. Preservative free bimatoprost and timolol solutions
US9061034B2 (en) 2010-07-29 2015-06-23 Allergan, Inc. Preservative free bimatoprost and timolol solutions
CZ2011676A3 (en) 2011-10-24 2013-05-02 Ústav organické chemie a biochemie Akademie ved CR, v.v.i. Carbonic anhydrase inhibitors and process for their preparation

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195085A (en) 1975-09-26 1980-03-25 Merck & Co., Inc. Compositions and methods for treating glaucoma by the topical administration of t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy-2-phopanol hydrogen maleate
US4160452A (en) 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4287175A (en) 1978-06-22 1981-09-01 Merck & Co., Inc. Contact lens wetting agents
IE50901B1 (en) * 1980-03-04 1986-08-06 Merck & Co Inc Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4416890A (en) 1981-07-13 1983-11-22 Merck & Co., Inc. Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
PT75625B (en) 1981-10-08 1985-12-09 Merck & Co Inc Process for preparing biosoluble ocular insert
US4386098A (en) 1981-11-03 1983-05-31 Merck & Co., Inc. 6-Hydroxy-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure
US4426388A (en) 1982-04-02 1984-01-17 Merck & Co., Inc. 5-Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
US4668697A (en) 1983-10-31 1987-05-26 Merck & Co., Inc. Elevated intraocular pressure lowering benzo-[b]-thiophene-2-sulfonamide derivatives, compositions, and method of use therefor
US4863922A (en) * 1984-12-12 1989-09-05 Merck & Co., Inc. Substituted aromatic sulfonamides as antiglaucoma agents, compositions and use
FR2588189B1 (en) 1985-10-03 1988-12-02 Merck Sharp & Dohme LIQUID-GEL PHASE TRANSITION PHARMACEUTICAL COMPOSITION
US5153192A (en) 1990-04-09 1992-10-06 Alcon Laboratories, Inc. Thiophene sulfonamides useful as carbonic anhydrase inhibitors
US5932572A (en) * 1992-02-21 1999-08-03 Alcon Laboratories, Inc. Topical anti-glaucoma compositions
AU677577B2 (en) 1992-02-21 1997-05-01 Alcon Laboratories, Inc. Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers

Also Published As

Publication number Publication date
ZA922809B (en) 1992-11-25
LT3368B (en) 1995-08-25
SG84487A1 (en) 2001-11-20
US6248735B1 (en) 2001-06-19

Similar Documents

Publication Publication Date Title
AU1456092A (en) Aptamers specific for thrombin and methods of use
HU9303218D0 (en) Application of atp-depended protease and its inhibitor for treatment of cachexy and amyotrophia
GB9227026D0 (en) Dual inhibitors of no synthase and cycloosygenase
AU5748194A (en) Mannitol derivatives and their use as inhibitors of aspartyl protease
BR9408462A (en) Specified nominal type of abrasive grain and abrasive article
EP0720708A4 (en) Belt tensioner and methods of making same
GB2254289B (en) Readily transferrable adherent tape and methods of use and making
HU893412D0 (en) Inhibitors of interleucin-1
IS3875A (en) Tray and method of freezing seafood
EP0419311A3 (en) Prodrugs of carbonic anhydrase inhibitors
NO170254C (en) MACHINE AND PROCEDURE FOR STORAGE OF FOODSTUFFS
EP0467660A3 (en) Use of d-limonenes as testosterone-5-alpha-reductase inhibitor and as hair grower
LTIP460A (en) Ophtalmic combinations of carbonic anhydrase inhibitors and b-blockers
ZA891439B (en) 4-amino-3-acylquinoline derivatives and their use as inhibitors of gastric secretion
AU6369094A (en) Ige isoforms and methods of use
ZA891442B (en) Heteroaryl 1-amino-3-acyquinoline derivatives and their use as inhibitors of gastric secretion
BR9306359A (en) Azoresants application of azoresis and crystalline modification
AU4709593A (en) Use of inhibitors of vacuolar-type H+ atpases
AU1850095A (en) Inhibitors of kynureninase
IL104648A0 (en) Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a prostaglandin or prostaglandin derivative
ZA891441B (en) 4-amino-3-acylquinolene derivatives and their use as inhibitors of gastric secretion
GB2260935B (en) Platters or vessels and method of making same
GB2251599B (en) Packaging and methods of making packaging
GB9008800D0 (en) Carbonic anhydrase inhibitors
GB2278620B (en) Protective walls and method of construction

Legal Events

Date Code Title Description
TK9A Rectifications: patents

Free format text: 1. OFTALMINE RECEPTURA, SKIRTA INDIVIDU PADIDINTO AKISPUDZIO GYDYMUI, I KURIOS SUDETI IEINA OFTALMOLOGINIU POZIURIU PRIIMTINAS NESIKLIS, NUO 0.5 IKI 5% (S/S) KARBONINES ANHIDRAZES INHIBITORIAUS ARBA JO OFTALMOLOGINIU POZIURIU PRIIMTINOS DRUSKOS IR NUO 0.01 IKI 1.0% BETA-BLOKATORIAUS ARBA JO OFTALMOLOGINIU POZIURIU PRIIMTINOS DRUSKOS.2. RECEPTURA PAGAL 1 PUNKTA, B E S I S K I R I A N T I TUO, KAD KARBONINES ANHIDRAZES INHIBITORIAUS KONCENTRACIJA YRA 0.5 IKI 3%, O BETA-BLOKATORIAUS KONCENTRACIJA YRA NUO 0.1 IKI 0.5%.3. OFTALMINE RECEPT

PD9A Change of patent owner

Owner name: MERCK SHARP & DOHME CORP., US

Effective date: 20121108

Owner name: SCHERING CORPORATION, US

Effective date: 20121108

MK9A Expiry of a patent

Effective date: 20130330